News | April 05, 2021
Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
PEL will explore the PLI scheme and apply if its beneficial.
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
nSEPIA aims to bring structure to an area long dominated by subjectivity
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Subscribe To Our Newsletter & Stay Updated
